These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38920247)

  • 21. Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings.
    Pandya BJ; Riedel AA; Swindle JP; Becker LK; Hariri A; Dabbous O; Krishnan E
    Curr Med Res Opin; 2011 Apr; 27(4):737-44. PubMed ID: 21271794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness of an adherence-enhancing intervention for gout based on real-world data.
    Lin LW; Teng GG; Lim AYN; Yoong JS; Zethraeus N; Wee HL
    Int J Rheum Dis; 2019 Apr; 22(4):545-554. PubMed ID: 30556300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allopurinol versus rilonacept for the prevention of gout flares: comment on the article by Schumacher et al.
    Meltzer M
    Arthritis Care Res (Hoboken); 2013 May; 65(5):838. PubMed ID: 23281274
    [No Abstract]   [Full Text] [Related]  

  • 25. [Febuxostat or allopurinol in patients with gout : Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)].
    Alten R; Mischkewitz M; Nitschmann S
    Internist (Berl); 2020 May; 61(5):530-532. PubMed ID: 32130437
    [No Abstract]   [Full Text] [Related]  

  • 26. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea.
    Park DJ; Kang JH; Lee JW; Lee KE; Wen L; Kim TJ; Park YW; Park SH; Lee SS
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):280-7. PubMed ID: 25047754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of inpatients with adverse drug reactions to allopurinol.
    Khoo BP; Leow YH
    Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gout: from international guidelines to current practice. Results from a physician questionnaire.
    Pascart T; Flipo RM
    Clin Rheumatol; 2013 Nov; 32(11):1693-4. PubMed ID: 24077902
    [No Abstract]   [Full Text] [Related]  

  • 30. Febuxostat efficacy in allopurinol-resistant tophaceous gout.
    Uh M; Reid G
    J Clin Rheumatol; 2011 Jun; 17(4):204-6. PubMed ID: 21617552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.
    Jacobs F; Mamzer-Bruneel MF; Skhiri H; Thervet E; Legendre C; Kreis H
    Transplantation; 1997 Oct; 64(7):1087-8. PubMed ID: 9381537
    [No Abstract]   [Full Text] [Related]  

  • 32. Gout: its causes, symptoms and treatment.
    Hill J
    Nurs Times; 1999 Nov 24-Dec 1; 95(47):48-50. PubMed ID: 11096905
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 34. Gout management: let's get it right this time.
    Sundy JS
    Arthritis Rheum; 2008 Nov; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract]   [Full Text] [Related]  

  • 35. Febuxostat versus allopurinol for gout.
    Gelber AC
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract]   [Full Text] [Related]  

  • 36. Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapy.
    Keith MP; Gilliland WR
    Clin Pharmacol Ther; 2011 Sep; 90(3):363-4. PubMed ID: 21862966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Febuxostat versus allopurinol for hyperuricemia].
    Ziegler R
    Med Monatsschr Pharm; 2006 Oct; 29(10):384. PubMed ID: 17058902
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors Influencing Allopurinol Initiation in Primary Care.
    Clarson LE; Hider SL; Belcher J; Roddy E; Mallen CD
    Ann Fam Med; 2017 Nov; 15(6):557-560. PubMed ID: 29133496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality use of allopurinol in the elderly.
    Smith P; Karlson N; Nair BR
    J Qual Clin Pract; 2000 Mar; 20(1):42-3. PubMed ID: 10821456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperuricemia and gout: a reign of complacency.
    Mandell BF
    Cleve Clin J Med; 2002 Aug; 69(8):589-90, 592-3. PubMed ID: 12184467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.